ATE354351T1 - Alginatgele mit verzögerter freisetzung - Google Patents

Alginatgele mit verzögerter freisetzung

Info

Publication number
ATE354351T1
ATE354351T1 AT98915592T AT98915592T ATE354351T1 AT E354351 T1 ATE354351 T1 AT E354351T1 AT 98915592 T AT98915592 T AT 98915592T AT 98915592 T AT98915592 T AT 98915592T AT E354351 T1 ATE354351 T1 AT E354351T1
Authority
AT
Austria
Prior art keywords
alginat
gels
delayed release
sustained
methods
Prior art date
Application number
AT98915592T
Other languages
English (en)
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE354351T1 publication Critical patent/ATE354351T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Fats And Perfumes (AREA)
AT98915592T 1997-04-17 1998-04-14 Alginatgele mit verzögerter freisetzung ATE354351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/842,756 US6656508B2 (en) 1997-04-17 1997-04-17 Sustained-release alginate gels

Publications (1)

Publication Number Publication Date
ATE354351T1 true ATE354351T1 (de) 2007-03-15

Family

ID=25288180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98915592T ATE354351T1 (de) 1997-04-17 1998-04-14 Alginatgele mit verzögerter freisetzung

Country Status (13)

Country Link
US (1) US6656508B2 (de)
EP (1) EP0975333B1 (de)
JP (1) JP2001524084A (de)
AT (1) ATE354351T1 (de)
AU (1) AU6973498A (de)
CA (1) CA2286092C (de)
DE (1) DE69837140T2 (de)
DK (1) DK0975333T3 (de)
ES (1) ES2283052T3 (de)
PT (1) PT975333E (de)
TW (1) TW577755B (de)
WO (1) WO1998046211A1 (de)
ZA (1) ZA983089B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6207718B1 (en) 1998-08-07 2001-03-27 Ontogeny, Inc. Pharmaceutical compositions containing hedgehog protein
PL347559A1 (en) 1998-10-28 2002-04-08 Snow Brand Milk Products Co Ltd Remedies for bone metabolic errors
IL144597A0 (en) * 1999-02-03 2002-05-23 Powderject Res Ltd Hydrogel particle formulations
AU770235B2 (en) * 1999-03-08 2004-02-19 Powderject Research Limited Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
PT1280521E (pt) 2000-05-12 2005-10-31 Pharmacia & Upjohn Co Llc Composicao de vacina, metodo para a sua preparacao, e metodo de vacinacao de vertebrados
EP1537860A1 (de) * 2000-05-12 2005-06-08 Pharmacia & Upjohn Company LLC Impfstoffzusammensetzung und Verfahren zur Herstellung derselben sowie Verfahren zur Impfung von Wirbeltieren
WO2002060410A2 (en) * 2001-01-30 2002-08-08 The Regents Of The University Of Michigan Methods for sustained release local delivery of drugs for ablation of unwanted tissue
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
EP1270015A3 (de) * 2001-06-29 2004-02-25 Sankyo Company Limited Ein Komplex enthaltend OCIF und einem Polysaccharid
JP2003081865A (ja) * 2001-09-12 2003-03-19 Ltt Institute Co Ltd 水不溶性徐放性組成物、その製剤及びその製造方法
US20040005999A1 (en) * 2002-03-07 2004-01-08 Andreasen Kasper Huus Polyamino acid-based particle insulin preparation
US6840196B2 (en) 2002-03-13 2005-01-11 Aspen Pet Products, Inc. Rawhide pet chew
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US8112400B2 (en) * 2003-12-23 2012-02-07 Texas Instruments Incorporated Method for collecting data from semiconductor equipment
FI116625B (fi) * 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
US20080058410A1 (en) * 2004-07-23 2008-03-06 Dpi Solutions, Inc. Composition for Stabilizing Vitamin C in Water Phase and Method for Stabilizing C Using Thereof
EP1807506B1 (de) * 2004-10-08 2013-04-17 Georgia Tech Research Corporation Mikroverkapselung von zellen in hydrogelen durch elektrostatische potentiale
AU2005295927B2 (en) * 2004-10-12 2012-02-02 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
US20060099550A1 (en) 2004-11-10 2006-05-11 Ranir/Dcp Corporation Device and method for delivering an oral care agent
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
WO2007147014A2 (en) * 2006-06-13 2007-12-21 Fmc Biopolymer As Method and systems for using biopolymer-based beads and hydrogels
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
GB0624227D0 (en) * 2006-12-05 2007-01-10 Common Services Agency Protein purification
JP5162134B2 (ja) * 2007-01-22 2013-03-13 愛媛県 機能性材料の製造方法、機能性材料、シート状構造体、及び衛生製品
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
US8809521B2 (en) * 2007-08-28 2014-08-19 Fmc Biopolymer As Delayed self-gelling alginate systems and uses thereof
EP2207568B1 (de) 2007-11-16 2017-05-31 The Rockefeller University Für die protofibrillenform des proteins beta-amyloid spezifische antikörper
CN102438657A (zh) * 2009-03-26 2012-05-02 沃萨乌整形外科公司 鉴别定向药物递送组合物的潜在组分的方法
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
MX2012008171A (es) * 2010-01-15 2012-12-17 Lithera Inc Formulaciones aglomeradas liofilizadas.
EP2590605A1 (de) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Biologisch abbaubare gerüste
EP2646012A4 (de) 2010-11-24 2014-12-10 Neothetics Inc Selektive, lipophile und langwirkende beta-agonisten-monotherapie-formulierungen sowie verfahren zur kosmetischen behandlung von adipositas und körperverformung
GB201120368D0 (en) 2011-11-24 2012-01-04 Sperm Vital As Methods for the preparation of hydrogels
CN103830266A (zh) * 2013-04-24 2014-06-04 杨亚勤 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用
US10383825B2 (en) 2015-08-13 2019-08-20 Temple University—Of the Commonwealth System of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
EP3414573B1 (de) 2016-02-10 2023-11-08 Rutgers, the State University of New Jersey Neue anti-lam antikörper
ES2910089T3 (es) 2016-04-13 2022-05-11 Lsi Medience Corp Inmunoensayo que emplea polisacárido sulfatado
US10981976B2 (en) 2016-08-31 2021-04-20 University Of Rochester Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof
JPWO2020045162A1 (ja) * 2018-08-30 2021-08-12 学校法人慶應義塾 薬物送達用担体
JP7768735B2 (ja) * 2021-11-16 2025-11-12 新田ゼラチン株式会社 生体吸収性粒子
WO2025212191A1 (en) * 2024-04-01 2025-10-09 Vitakey Inc. Heat-treated extended-release formulations

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507193A (en) 1949-05-17 1950-05-09 Bristol Lab Inc Penicillin product
US2882203A (en) 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
US2741573A (en) 1953-12-28 1956-04-10 Abbott Lab Penicillin compositions for intramuscular injection
US3676557A (en) 1971-03-02 1972-07-11 Endo Lab Long-acting narcotic antagonist formulations
JPS5416979B2 (de) 1972-01-08 1979-06-26
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4400391A (en) * 1980-01-09 1983-08-23 The United States Of America As Represented By The Secretary Of Agriculture Controlled release of bioactive materials using alginate gel beads
US4789516A (en) 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4690682A (en) 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4695463A (en) 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
CA2046324A1 (en) 1989-01-26 1990-07-27 Wen-Ghih Tsang Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5175093A (en) * 1989-11-07 1992-12-29 Lehigh University Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
CA2121129A1 (en) * 1991-10-29 1993-05-13 Patrick Soon-Shiong Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5711968A (en) 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5451411A (en) * 1993-10-15 1995-09-19 University Of Washington Methods and compositions for the oral delivery of therapeutic agents
JPH10503179A (ja) 1994-06-24 1998-03-24 イミュネックス・コーポレーション 放出制御性ポリペプチド組成物および炎症性腸疾患の治療方法
US5629184A (en) 1995-01-25 1997-05-13 Amgen Inc. Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
WO1997001331A2 (en) 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
AU2246097A (en) 1996-01-25 1997-08-20 Eli Lilly And Company Obesity protein analog compounds and formulations thereof
JP2000506517A (ja) 1996-02-06 2000-05-30 イーライ・リリー・アンド・カンパニー 肥満症タンパク質化合物およびその製剤

Also Published As

Publication number Publication date
CA2286092A1 (en) 1998-10-22
WO1998046211A1 (en) 1998-10-22
DE69837140T2 (de) 2007-11-29
CA2286092C (en) 2004-12-14
TW577755B (en) 2004-03-01
DK0975333T3 (da) 2007-06-18
US6656508B2 (en) 2003-12-02
ES2283052T3 (es) 2007-10-16
EP0975333B1 (de) 2007-02-21
EP0975333A1 (de) 2000-02-02
US20020001619A1 (en) 2002-01-03
PT975333E (pt) 2007-05-31
AU6973498A (en) 1998-11-11
JP2001524084A (ja) 2001-11-27
ZA983089B (en) 1998-10-19
DE69837140D1 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
DE69837140D1 (de) Alginatgele mit verzögerter freisetzung
ATE343378T1 (de) Biologisch abbaubares alginatgel mit verzögerter freisetzung
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
DE69326809D1 (de) Alginatgel
DE69832558D1 (de) Kompressionssystem
BR9610156A (pt) Composição em gel
DK0784651T3 (da) Alginatgeler
NO902386L (no) Alginatgeler.
MXPA02004666A (es) Gelatinas recombinantes.
ID30075A (id) Partikel gel superserap multikomponen
FI974141A7 (fi) Viestin sisällön hyödyntäminen
DE69826840D1 (de) Beleuchtungssystem
DE69507456D1 (de) Linsenraster verwendendes beleuchtungssystem
CY2005011I1 (el) ΑΝΘΡΩΠΙΝΑ ΑΝΤΙΣΩΜΑΤΑ ΤΑ ΟΠΟΙΑ ΔΕΣΜΕΥΟΥΝ ΤΟΝ ΑΝΘΡΩΠΙΝΟ TNFα
DE69823153D1 (de) Software-Emulationssystem
FI973198L (fi) Silloitetut indolit matriisimetalloproteaasi-inhibiittoreina
DE69601182D1 (de) Silicongelzusammensetzung
FI98495B (fi) Palonsammutuslaitteisto
DE19880705T1 (de) Bremssystem
KR970033836U (ko) 차량용 소화기 고정장치
KR970042768U (ko) 터보 차저를 이용한 브레이크 냉각장치
DE69718300D1 (de) Gel-dichtung
BR9503177A (pt) Gel dental
NO952436D0 (no) Stearinlysslukker
KR970056576U (ko) 신발에 반사물 붙임

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975333

Country of ref document: EP

REN Ceased due to non-payment of the annual fee